Potential antidepressant effects of Traditional Chinese botanical drug formula Chaihu-Shugan-San and its active ingredients

Potential antidepressant effects of Traditional Chinese botanical drug formula Chaihu-Shugan-San and its active ingredients

Background: Depression is a severe mental disorder that poses a significant threat to both the physical and mental wellbeing of individuals. Currently, there are various methods for treating depression, including traditional Chinese herbal formulations like Chaihu-Shugan-San (CSS), which have shown...

Full description

Bibliographic Details
Main Authors:	Ziyi Guo, Tianjian Long, Jianping Yao, Yamin Li, Lu Xiao, Min Chen
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2024-04-01
Series:	Frontiers in Pharmacology
Subjects:	Chaihu-Shugan-San depression active ingredients antidepressant systematic review
Online Access:	https://www.frontiersin.org/articles/10.3389/fphar.2024.1337876/full

Similar Items

Chaihu-Shugan-San ameliorates tumor growth in prostate cancer promoted by depression via modulating sphingolipid and glycerinphospholipid metabolism
by: Wei Li, et al.
Published: (2022-12-01)

Reporting quality and risk of bias assessment of animal research on Chaihu-Shugan-San for depression: A systematic review
by: Xiao Zhu, et al.
Published: (2023-08-01)

Network Pharmacology and Experimental Evidence: PI3K/AKT Signaling Pathway is Involved in the Antidepressive Roles of Chaihu Shugan San
by: Zhang S, et al.
Published: (2021-08-01)

SIRT1/FOXO1 Axis-Mediated Hippocampal Angiogenesis is Involved in the Antidepressant Effect of Chaihu Shugan San
by: Zhang S, et al.
Published: (2022-08-01)

Proteomics Study Reveals the Anti-Depressive Mechanisms and the Compatibility Advantage of Chaihu-Shugan-San in a Rat Model of Chronic Unpredictable Mild Stress
by: Xiaofei Zhu, et al.
Published: (2022-01-01)

Chaihu-Shugan-San inhibits neuroinflammation in the treatment of post-stroke depression through the JAK/STAT3-GSK3β/PTEN/Akt pathway
by: Qiqi Fan, et al.
Published: (2023-04-01)

Chaihu Shugan prevents cholesterol gallstone formation by ameliorating the microbiota dysbiosis and metabolic disturbance in mice
by: Wei Wang, et al.
Published: (2024-01-01)

Chaihu Shugan San ameliorated cognitive deficits through regulating gut microbiota in senescence-accelerated mouse prone 8
by: Zhiyue Li, et al.
Published: (2023-05-01)

Chaihu-shugan-san alleviates depression-like behavior in mice exposed to chronic unpredictable stress by altering the gut microbiota and levels of the bile acids hyocholic acid and 7-ketoDCA
by: Chong Ma, et al.
Published: (2022-10-01)

A Chinese Classical Prescription Chaihu Shugan Powder in Treatment of Post-Stroke Depression: An Overview
by: Zu Gao, et al.
Published: (2022-12-01)

The Modulation of Chaihu Shugan Formula on Microbiota Composition in the Simulator of the Human Intestinal Microbial Ecosystem Technology Platform and its Influence on Gut Barrier and Intestinal Immunity in Caco-2/THP1-Blue™ Cell Co-Culture Model
by: Ling Liu, et al.
Published: (2022-03-01)

Chaihu-Shugan-San exerts an antidepressive effect by downregulating miR-124 and releasing inhibition of the MAPK14 and Gria3 signaling pathways
by: Qiong Liu, et al.
Published: (2018-01-01)

Commentary: The Modulation of Chaihu Shugan Formula on Microbiota Composition in the Simulator of the Human Intestinal Microbial Ecosystem Technology Platform and Its Influence on Gut Barrier and Intestinal Immunity in Caco-2/THP1-Blue™ Cell Co-Culture Model
by: Yang Yu, et al.
Published: (2022-06-01)

Chaihu Shugan powder alleviates liver inflammation and hepatic steatosis in NAFLD mice: A network pharmacology study and in vivo experimental validation
by: Sisi Lei, et al.
Published: (2022-09-01)

Involvement of NMDA-AKT-mTOR Signaling in Rapid Antidepressant-Like Activity of Chaihu-jia-Longgu-Muli-tang on Olfactory Bulbectomized Mice
by: Xing Wang, et al.
Published: (2019-01-01)

Mechanism of Shugan Yidan fang, a Chinese herbal formula, in rat model of premature ejaculation
by: Qiang Han, et al.
Published: (2023-10-01)

Bile duct perfusion of Chaihu Paishi Decoction combined with duodenoscopy in treatment of difficult choledocholithiasis
by: TANG Tengqian, et al.
Published: (2021-02-01)

Gut Microbiota Is the Key to the Antidepressant Effect of Chaihu-Shu-Gan-San
by: Meng Yu, et al.
Published: (2020-02-01)

Chaihu Oral Liquid improves hippocampal neurogenesis and short-term memory defects in adult BTBR autism mice
by: CHEN Mei, et al.
Published: (2022-05-01)

Unveiling the Mechanism of the ChaiShao Shugan Formula Against Triple-Negative Breast Cancer
by: Fan T, et al.
Published: (2024-04-01)

Antidepressant Active Ingredients From Chinese Traditional Herb Panax Notoginseng: A Pharmacological Mechanism Review
by: Yanwei Li, et al.
Published: (2022-06-01)

Metagenomics and metabolomics analysis to investigate the effect of Shugan decoction on intestinal microbiota in irritable bowel syndrome rats
by: Lu Hang, et al.
Published: (2022-11-01)

Effectiveness of Shugan Jieyu capsules for psychiatric symptoms of epilepsy: a systematic review and meta-analysis
by: Sejin Kim, et al.
Published: (2024-01-01)

A network pharmacology and molecular docking approach to reveal the mechanism of Chaihu Anxin Capsule in depression
by: Lin Yang, et al.
Published: (2023-09-01)

Chaihu-Shugan-San administration ameliorates perimenopausal anxiety and depression in rats.
by: Shujiao Chen, et al.
Published: (2013-01-01)

Antidepressant Shugan Jieyu Capsule Alters Gut Microbiota and Intestinal Microbiome Function in Rats With Chronic Unpredictable Mild Stress -Induced Depression
by: Jingxuan Tan, et al.
Published: (2022-06-01)

Antidepressant and Anti-Neuroinflammatory Effects of Bangpungtongsung-San
by: Bo-Kyung Park, et al.
Published: (2020-07-01)

Effect of fluoxetine combined with Shugan Jieyu capsule in the treatment of patients with depression and its impact on heart rate variability
by: Zhao Yuanyuan, et al.
Published: (2023-10-01)

Effectiveness of the Shugan Jieyu Capsule against Psychiatric Symptoms in Epilepsy: a protocol for systematic review and meta-analysis
by: Sejin Kim, et al.
Published: (2023-03-01)

The pharmacological mechanism of chaihu-jia-longgu-muli-tang for treating depression: integrated meta-analysis and network pharmacology analysis
by: Yang Zhao, et al.
Published: (2023-09-01)

Chaihu-Guizhi-Ganjiang Decoction is more efficacious in treating irritable bowel syndrome than Dicetel according to metabolomics analysis
by: Mingming Li, et al.
Published: (2022-12-01)

The efficacy of Da Chaihu decoction combined with metformin tablets for type 2 diabetes mellitus: A systematic review and meta-analysis
by: Jia-bin Wang, et al.
Published: (2022-12-01)

Application of Intranasal Administration in the Delivery of Antidepressant Active Ingredients
by: Zhiyu Jin, et al.
Published: (2022-09-01)

Chaihu Guizhi Ganjiang Decoction Ameliorates Pancreatic Fibrosis via JNK/mTOR Signaling Pathway
by: Lihua Cui, et al.
Published: (2021-06-01)

Searching the cytochrome p450 enzymes for the metabolism of meranzin hydrate: a prospective antidepressant originating from Chaihu-Shugan-San.
by: Xi Huang, et al.
Published: (2014-01-01)

Study on the mechanism of Shugan Lidan Xiaoshi granule in preventing acute pancreatitis based on network pharmacology and molecular docking
by: Jiaxing Wang, et al.
Published: (2024-03-01)

Shugan Decoction Alleviates Colonic Dysmotility in Female SERT-Knockout Rats by Decreasing M3 Receptor Expression
by: Yinshu Wang, et al.
Published: (2020-09-01)

Study on the Mechanism of Shugan Xiaozhi Fang on Cells with Non-alcoholic Fatty Liver Disease
by: Xing Yufeng, et al.
Published: (2019-12-01)

Proprietary Medicines Containing Bupleurum chinense DC. (Chaihu) for Depression: Network Meta-Analysis and Network Pharmacology Prediction
by: Qiao-feng Li, et al.
Published: (2022-04-01)

Chaihu-Longgu-Muli decoction improves sleep disorders by restoring orexin-A function in CKD mice
by: Xin-li Cao, et al.
Published: (2023-06-01)